Purdue researchers apply new technique to manipulate virus, make it a possible cancer treatment
November 27, 2013
WEST LAFAYETTE, Ind. — Purdue University researchers successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector.
"This virus had been known to be a good vector for delivering therapeutic cargo, however it naturally infected all kinds of cells, and these diversions would compete with what we were instructing it to target," said Richard Kuhn, the Gerald and Edna Mann Director of Purdue's Bindley Biosciences Center. "We have now overcome a major challenge by not only inserting a targeting molecule of our choice, but also successfully stripping the virus of its native entry preferences. This was a big step in unlocking the potential of developing this virus into a platform for both targeted drug delivery, where it would sneak drugs inside cancer cells, and oncolytic virotherapy, where the virus itself destroys cancer cells."
- Elizabeth K. Gardner, Writer
November 26, 2014
The candidates for the position of the director of the Discovery Learning Research Center (DLRC) will give seminars on their vision for the future of the DLRC.Read Full Story
November 25, 2014
Spero Energy Inc., whose technology could make biofuel production more efficient and creates high-value, renewable chemicals used in the flavor and fragrance industry, has been awarded a $50,000 grant.Read Full Story
November 24, 2014
Researchers at Nano-Meta Technologies Inc. (NMTI) in the Purdue Research Park have shown how to overcome key limitations of a material that could enable the magnetic storage industry to achieve data-recording densities far beyond today's computers.Read Full Story